ProMIS Neurosciences Inc Sustainability Reports
ProMIS Neurosciences Inc. is a clinical-stage biotechnology company discovering and developing selective antibody therapeutics and vaccines. Its treatments target toxic misfolded proteins associated with neurodegenerative diseases like Alzheimer's, ALS, and Parkinson's.
Sector: Manufacturing
Country: Canada
Exchange: Nasdaq
LEI: 5299007HZF79F9IAXI53
FIGI: BBG001SMDG62
2 reports from 2023 to 2024
